The Medical Imaging and Technology Alliance (MITA) is partnering with the Focused Ultrasound Foundation to educate policymakers, payors, and medical specialty societies about the therapeutic advantages of focused ultrasound.
Patrick Hope, executive director of MITA, cited recent developments in focused ultrasound and the potential of the image-guided technology to help treat a range of conditions, including cancer and functional disorders of the brain.
"Our work together will help create a culture of collaboration that will benefit patients, providers, and manufacturers by accelerating the acceptance and adoption of therapeutic focused ultrasound," added Mark Carol, president and CEO of high-intensity focused ultrasound developer SonaCare Medical and chairman of MITA's Focused Ultrasound Working Group.
